Kura Oncology Inc shares rose 5.4% in after-hours trading Monday following an insider stock purchase by the company’s President and CEO, Troy Edward Wilson. Wilson acquired 100,000 shares of common stock on August 17, 2026, at a weighted average price of $11.12 per share. The transaction was executed in multiple trades at prices ranging from $10.87 to $11.31. Following the purchase, Wilson beneficially owns 379,194 shares indirectly through the One Fish Two Fish Revocable Trust, 300,000 shares indirectly through the Lorax Charitable Remainder Unitrust, and 435,456 shares directly. Insider purchases are often viewed as a positive signal by market participants, as executives typically have access to detailed information about their company’s operations and prospects.
Markets
Markets